Chirurgia citoriduttiva (peritonectomia) e chemio ipertermia intra peritoneale: un approccio innovativo ed efficace nel trattamento dello pseudomixoma peritonei.

Translated title of the contribution: Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei

M. Deraco, S. Kusamura, A. Gronchi

Research output: Contribution to journalArticle

Abstract

Pseudomyxoma peritonei is a rare disease characterized by a complete redistribution of mucin into the peritoneal cavity. Thirty three PMP patients referred to National Cancer Institute of Milan were submitted to 34 consecutive procedures of peritonectomy and intra peritoneal hyperthermic perfusion (IPHP). Five yrs overall survival has been 96% while 3 yrs PFS 68%. Morbility, mortality and toxicity were 18, 3 and 9% respectively. Peritonectomy associated with IPHP is the most indicated approach to cure patients with DPAM and IFG, subgroup of pseudomyxoma peritonei.

Translated title of the contributionCytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei
Original languageItalian
Pages (from-to)54-55
Number of pages2
JournalTumori
Volume89
Issue number4 Suppl
Publication statusPublished - Jul 2003

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei'. Together they form a unique fingerprint.

  • Cite this